Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s share price was up 4.9% during trading on Thursday . The stock traded as high as $7.17 and last traded at $7.32. 382,366 shares changed hands during trading, a decline of 94% from the average session volume of 6,218,646 shares. The stock had previously closed at $6.97.
Analyst Ratings Changes
TDOC has been the subject of several recent analyst reports. Citigroup decreased their price objective on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a report on Friday, April 25th. Canaccord Genuity Group lowered their price target on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. The Goldman Sachs Group dropped their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Bank of America decreased their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Finally, Evercore ISI lowered their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, Teladoc Health presently has a consensus rating of "Hold" and an average price target of $9.60.
Read Our Latest Research Report on TDOC
Teladoc Health Trading Down 0.5%
The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $7.26 and a 200 day moving average price of $9.20. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of -1.19 and a beta of 1.82.
Insider Activity at Teladoc Health
In other news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.58% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of TDOC. Strs Ohio acquired a new stake in shares of Teladoc Health in the first quarter valued at about $349,000. Acadian Asset Management LLC acquired a new stake in Teladoc Health in the 1st quarter valued at approximately $615,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Teladoc Health by 5.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider's stock worth $3,566,000 after buying an additional 24,124 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of Teladoc Health by 1,278.7% during the first quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock worth $90,000 after buying an additional 10,485 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Teladoc Health by 2.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider's stock valued at $1,542,000 after acquiring an additional 5,235 shares during the period. Institutional investors own 76.82% of the company's stock.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
